Granite Investment Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-211,086
Closed -$3.08M 298
2020
Q4
$3.08M Sell
211,086
-9,022
-4% -$120K 0.11% 162
2020
Q3
$3.13M Sell
220,108
-16,449
-7% -$251K 0.14% 139
2020
Q2
$3.48M Sell
236,557
-521,321
-69% -$5.3M 0.17% 132
2020
Q1
$3.12M Buy
757,878
+168,565
+29% +$790K 0.2% 123
2019
Q4
$2.83M Buy
589,313
+169,640
+40% +$936K 0.13% 157
2019
Q3
$2.54M Buy
419,673
+112,393
+37% +$701K 0.13% 142
2019
Q2
$1.99M Buy
307,280
+131,857
+75% +$929K 0.11% 147
2019
Q1
$1.24M Buy
175,423
+37,926
+28% +$250K 0.07% 187
2018
Q4
$668K Buy
137,497
+25,592
+23% +$133K 0.05% 216
2018
Q3
$823K Buy
111,905
+11,280
+11% +$82.8K 0.05% 189
2018
Q2
$642K Sell
100,625
-120,361
-54% -$796K 0.04% 211
2018
Q1
$1.2M Buy
220,986
+5,226
+2% +$26K 0.08% 159
2017
Q4
$900K Buy
215,760
+130,677
+154% +$786K 0.06% 233
2017
Q3
$819K Buy
+85,083
New +$884K 0.05% 234

Other funds holding GNMK

Granite Investment Partners's GNMK Position: Q1 2021 in Review

Granite Investment Partners sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 211,086 shares — an estimated $3.08M sold.

Granite Investment Partners first reported a position in GNMK in Q3 2017 and held it in 14 quarters. The position peaked at $3.48M in Q2 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Granite Investment Partners reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Granite Investment Partners sold 211,086 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $3.08M.
  • Granite Investment Partners first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 14 quarters.
  • Granite Investment Partners's GenMark Diagnostics, Inc position peaked at $3.48M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Granite Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.